Last reviewed · How we verify
NCT04861896
A Research Study for Latina Women With Breast Cancer
NA trial testing "My Guide" (psychoeducation & self-management program) in Cancer, Breast in 58 participants. Completed in 7 November 2023.
25 October 2022
Quick facts
| Lead sponsor | Northwestern University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 58 |
| Start date | 1 April 2021 |
| Primary completion | 25 October 2022 |
| Estimated completion | 7 November 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- "My Guide" (psychoeducation & self-management program)
Conditions studied
- Cancer, Breast — all drugs for Cancer, Breast →
- Cancer-related Problem/Condition — all drugs for Cancer-related Problem/Condition →
- Quality of Life — all drugs for Quality of Life →
- Hormone Dependent Neoplasms — all drugs for Hormone Dependent Neoplasms →
Sponsor
Northwestern University
Who can join
18 and older, female only, with Cancer, Breast or Cancer-related Problem/Condition. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to examine the feasibility and preliminary efficacy of a psychosocial eHealth intervention designed to improve hormone therapy adherence among Hispanic/Latinx women with breast cancer. Our proposed secondary outcomes are health-related quality of life and self-efficacy in managing hormone therapy side effects. The intervention components include breast cancer knowledge, hormone/endocrine therapy knowledge, stress awareness and management, social support, and enhanced communication and intimacy skills. The intervention will be delivered via a Smartphone application over a 12-week period. All participants will receive the intervention application (described below). Aside from using the Smartphone application for the recommended 12 weeks, participation in this study includes three assessments: baseline (at the beginning of the research study), 6-week follow-up, and 12-week follow-up.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04861896
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of "My Guide" (psychoeducation & self-management program)
Trials testing the same drug.
- NCT03645005 — A Research Study for Latina Women After Breast Cancer Treatment · NA · completed
Other recruiting trials for Cancer, Breast
Currently open trials in the same condition.
- NCT06672120 — Exercise in Triple- Negative Breast Cancer · NA · recruiting
- NCT06345534 — FAST-FORWARD vs HAI5 · NA · recruiting
- NCT05721976 — With Love, Grandma ("Con Cariño, Abuelita") Pilot Study · NA · recruiting
- NCT04258813 — Onco-primary Care Networking to Support TEAM-based Care · NA · active not recruiting
- NCT05289258 — Unified Barlow Protocol (UP) in Cancer Survivors for Cognitive Impairments · NA · recruiting
Other Northwestern University trials
Trials by the same sponsor.
- NCT06545695 — Epidermal Growth Factor Receptor Inhibition for Keratinopathies · Phase 1, PHASE2 · not yet recruiting
- NCT07261657 — N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive C · EARLY_PHASE1 · not yet recruiting
- NCT07392775 — ALDH2 Genetic Testing in East Asian Community · NA · not yet recruiting
- NCT06886776 — Implementing A Secure Firearm Storage Program in Illinois Health Centers in Partnership With AllianceChicago and the Ill · NA · not yet recruiting
- NCT07469176 — Co-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04861896 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Northwestern University
- Last refreshed: 8 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04861896.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing